Alanine mutation
of ECL2 and ECL3 has distinct effects on pERK
peptide efficacy for AMY3R and CTR. Peptide efficacy, derived
from operational fitting of concentration–response curves in
pERK, are displayed as Δlog τc from wild-type
for AMY3R (A–E) and CTR (F–J). Illustrated
are top views of the receptors with the extracellular surface subject
to alanine scanning depicted (combined surface/cpk representation).
Mutations that significantly alter peptide functional log τc are colored according to the magnitude of effect, with mutated
amino acids without significant alteration to log τc colored gray. Amino acid mutations for which there was an insufficiently
robust functional effect to quantify by operational modeling are depicted
in black. The receptor ECD and peptide are not shown for clarity,
with the CTR TM bundle in blue ribbon and RAMP3 in green ribbon in
A–E, and CTR TM bundling in red ribbon in F–J. Data
for CTR peptide efficacy are from Dal Maso et al., 2018.17